LONDON: Millions of British workers could retire with larger pension pots under government plans to double the number of U.K. pension “megafunds” by 2030, unlocking billions for domestic investment. Reforms set out in the upcoming Pension Schemes Bill will require multi-employer defined…
LONDON: The UK Government has released its AI Opportunities Action Plan, presented to Parliament by the Secretary of State for Science, Innovation and Technology on January 13, 2025. The plan aims to secure the UK’s future with homegrown AI and…
X-Energy UK Holdings, Ltd, a subsidiary of X-Energy Reactor Company, LLC, and Cavendish Nuclear, part of Babcock International, have received a substantial funding boost from the UK Government’s Future Nuclear Enabling Fund (FNEF). The £3.34 million grant, which will be…
Nova Innovation and Atlantis Energy welcome the UK Government’s announcement of funding for tidal stream energy and look forward to delivering more turbines in the water at the world-leading MeyGen site Nova Innovation (Nova) and Atlantis Energy (Atlantis) have welcomed…
SAINT-HERBLAIN: Valneva SE reported the UK Government has exercised its option to order 40 million doses of its inactivated, adjuvanted COVID-19 vaccine candidate for supply in 2022. This brings the total volume of the Valneva vaccine ordered by UK Government…
LONDON: Open Orphan plc (ORPH) announced the signing of a contract by hVIVO, a subsidiary of Open Orphan, with the UK Government to develop a COVID-19 (SARS-CoV-2) human challenge study model. The model development involves the manufacture of the challenge…
SINGAPORE: Elite Commercial REIT Management , the manager of Elite Commercial REIT provided an update on its primary tenant, the United Kingdom (UK) Government’s Department Of Work And Pensions (DWP)’s operations and activities, in light of recent developments in the…
LONDON: Sanofi and have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. The vaccine candidate, developed by Sanofi in partnership with GSK, is based…